Engineering enhanced chimeric antigen receptor-T cell therapy for solid tumors
{{output}}
The early clinical success and subsequent US Food and Drug Administration approval of chimeric antigen receptor (CAR)-T cell therapy for leukemia and lymphoma affirm that engineered T cells can be a powerful treatment for hematologic malignancies. Yet this suc... ...
